
Secretory products of the corpus luteum and preeclampsia
Author(s) -
Maria Monica Pereira,
Monica Mainigi,
Jerome F. Strauss
Publication year - 2021
Publication title -
human reproduction update
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.977
H-Index - 180
eISSN - 1362-4946
pISSN - 1355-4786
DOI - 10.1093/humupd/dmab003
Subject(s) - corpus luteum , preeclampsia , pregnancy , placentation , medicine , endometrium , placenta , narrative review , obstetrics , gynecology , uterine fibroids , bioinformatics , physiology , endocrinology , biology , hormone , fetus , intensive care medicine , genetics
Despite significant advances in our understanding of the pathophysiology of preeclampsia (PE), there are still many unknowns and controversies in the field. Women undergoing frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium have been found to have an unexpected increased risk of PE compared to women who receive embryos in a natural FET cycle. The differences in risk have been hypothesized to be related to the absence or presence of a functioning corpus luteum (CL).